Our press documents

You are a journalist and you would like to receive our press releases by e-mail? Please, ask to presse@pasteur.fr

Filter press documents

Press Info
10.09.2020
Epidemiological theory teaches us that a microbial agent introduced into a population stops circulating when the...
COVID-19 : un projet vaccin lentiviral par voie intra-nasale assure une protection importante chez l’animal
Press release
25.08.2020
In a preprint on BioRxiv, scientists from the Pasteur-TheraVectys joint lab have disseminated animal test results for...
Press release
12.08.2020
Since the late 1990s, immunotherapy has been the frontline treatment against lymphomas where synthetic antibodies are...
Press release
27.07.2020
Resistance to artemisinin, the main component of the current antimalarial treatments recommended by WHO, is already...
Press release
15.07.2020
Which patients will develop a severe form of Covid-19? This is a key question that needs to be answered to improve the...
Press release
06.07.2020
Every winter, seasonal coronaviruses are responsible for repeated colds and bronchitis from early childhood onwards....
Covid-19 dans les écoles primaires : pas de transmission importante du virus entre enfants ou vers les enseignants
Press release
23.06.2020
In late April 2020, scientists at the Institut Pasteur, with the support of the Hauts-de-France Regional Health Agency...
Une étude préclinique montre que l’hydroxychloroquine n’a pas d’effet antiviral contre le SARS-CoV-2 in vivo
Press release
29.05.2020
A study on the effects of hydroxychloroquine n macaques infected with the SARS-CoV-2 virus, used alone or in...
Candidat vaccin MV-SARS-CoV-2 : un nouveau partenariat entre l’Institut Pasteur, la CEPI, Thémis et MSD
Press release
26.05.2020
Institut Pasteur announces recent advances in the development of one of its candidate vaccines, MV-SARS-CoV-2, using...

Pages

Back to top